Meget™ is a synthetic progestin containing 160 mg of Megestrol Acetate. It is used primarily in the palliative treatment of advanced breast and endometrial cancer. Additionally, it serves as an appetite stimulant for patients with anorexia, cachexia, or significant weight loss due to conditions like cancer or AIDS. The medication works by influencing hormonal pathways, helping to manage symptoms of hormone-dependent cancers and promote weight gain in wasting conditions.